Learn More
The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32% reduction in breast cancer mortality. Mammographic screening for breast cancer continues to save lives after up to 20 years. Screening derives this benefit by improving the distribution of tumors diagnosed with respect to prognostic(More)
A cohort comprising 11,452 women and based on virtually all cases of first incidence of breast cancer in Sweden in 1964-67 was followed for 13-16 completed years--corresponding to 94,078 person-years of observation--for the occurrence of subsequent primary tumors other than in the breast. A slight excess in the total number of second malignant diseases (695(More)
OBJECTIVE To learn about the natural history of untreated, early-stage prostatic cancer. DESIGN Cohort study with a mean follow-up of 123 months (range, 81 to 165 months). SETTING Population-based, regionally well defined. PATIENTS A consecutive sample of 223 patients (98% of all eligible) with early-stage (T0-2, NX, M0), initially untreated prostatic(More)
OBJECTIVE To evaluate primary hyperparathyroidism (HPT) as a risk factor for hip fractures. DESIGN A population-based, record-linked, prospective study with a mean observation time of 17 years (women) and 16.5 years (men). SETTING A cohort obtained from a register of hospital admissions in the Uppsala Health Care Region, Sweden, 1965-1983. (More)
The incidence of colorectal cancer after cholecystectomy was analysed in a historical population-based cohort study comprising 16,439 patients who were completely followed up for 14-17 years after operation. The observed number of colorectal cancers (150) was lower than the expected number of 166.3 (relative risk (RR) = 0.90:95 per cent confidence limits(More)
The risk of developing a second primary cancer was studied among 34,506 gastric cancer patients identified through the Swedish Cancer Registry. A second cancer was reported in 962 patients compared to an expected number of 826 (relative risk = 1.16, 95% confidence limits = 1.09-1.24). The slightly but significantly elevated risk was largely confined to the(More)
The association between survival in breast cancer and menopausal hormone treatment prior to diagnosis was analyzed by comparing 261 women who developed the disease in a population-based cohort of estrogen-treated women with 6,617 breast cancer patients without any recorded estrogen treatment drawn from the same population. Complete follow-up was achieved(More)
The importance of cholecystectomy as a risk factor for colorectal cancer was analyzed in an historical cohort study covering 16,773 cases during 11-14 years completed after operation. The observed number of colorectal cancers (130) was lower than the expected 153.5 [relative risk (RR) = 0.85]. For cancer of the colon, the observed number was 87, which was(More)
We analyzed the survival trend after cancer was diagnosed by complete follow-up through 1986 of 591,456 (99.4%) of all those patients in whom a first malignant disease was diagnosed in Sweden from 1960 to 1984. From 1960-1964 to 1980-1984, the 5-year relative survival increased from 34.2% to 47.1% in males and from 48.7% to 56.9% in females. The mean loss(More)
The occurrence of a second primary malignant disease was analyzed in 38,166 patients with cancer of the colon and 23,603 patients with rectal cancer reported to the Swedish Cancer Registry between 1960 and 1981. The overall relative risk (RR) of developing a second primary malignant disease was significantly (P less than 0.05) increased both after cancer of(More)